These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8786388)

  • 21. Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions.
    Koning N; Swaab DF; Hoek RM; Huitinga I
    J Neuropathol Exp Neurol; 2009 Feb; 68(2):159-67. PubMed ID: 19151626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variations on brain microglial gene expression of MMPs, RECK, and TIMPs in inflammatory and non-inflammatory diseases in dogs.
    Stein VM; Puff C; Genini S; Contioso VB; Baumgärtner W; Tipold A
    Vet Immunol Immunopathol; 2011 Nov; 144(1-2):17-26. PubMed ID: 21802747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states.
    Pagenstecher A; Stalder AK; Kincaid CL; Shapiro SD; Campbell IL
    Am J Pathol; 1998 Mar; 152(3):729-41. PubMed ID: 9502415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury.
    Buss A; Pech K; Kakulas BA; Martin D; Schoenen J; Noth J; Brook GA
    BMC Neurol; 2007 Jun; 7():17. PubMed ID: 17594482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution.
    Cuzner ML; Gveric D; Strand C; Loughlin AJ; Paemen L; Opdenakker G; Newcombe J
    J Neuropathol Exp Neurol; 1996 Dec; 55(12):1194-204. PubMed ID: 8957442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Matrix metalloproteinases in the central nervous system: clinical significance and therapeutic prospects].
    Sulik A; Ołdak E
    Pol Merkur Lekarski; 2008 Mar; 24(141):278-80. PubMed ID: 18634301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.
    Peferoen LA; Gerritsen WH; Breur M; Ummenthum KM; Peferoen-Baert RM; van der Valk P; van Noort JM; Amor S
    Acta Neuropathol Commun; 2015 Dec; 3():87. PubMed ID: 26694816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microglial functions and proteases.
    Nakanishi H
    Mol Neurobiol; 2003 Apr; 27(2):163-76. PubMed ID: 12777686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ADAM-10 and ADAM-17 in the inflamed human CNS.
    Kieseier BC; Pischel H; Neuen-Jacob E; Tourtellotte WW; Hartung HP
    Glia; 2003 Jun; 42(4):398-405. PubMed ID: 12730960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. White matter extracellular matrix chondroitin sulfate/dermatan sulfate proteoglycans in multiple sclerosis.
    Sobel RA; Ahmed AS
    J Neuropathol Exp Neurol; 2001 Dec; 60(12):1198-207. PubMed ID: 11764092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinases in the CNS: interferons get nervous.
    Chopra S; Overall CM; Dufour A
    Cell Mol Life Sci; 2019 Aug; 76(16):3083-3095. PubMed ID: 31165203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein.
    Calderon TM; Eugenin EA; Lopez L; Kumar SS; Hesselgesser J; Raine CS; Berman JW
    J Neuroimmunol; 2006 Aug; 177(1-2):27-39. PubMed ID: 16782208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of IL-1β in rhesus EAE and MS lesions is mainly induced in the CNS itself.
    Burm SM; Peferoen LA; Zuiderwijk-Sick EA; Haanstra KG; 't Hart BA; van der Valk P; Amor S; Bauer J; Bajramovic JJ
    J Neuroinflammation; 2016 Jun; 13(1):138. PubMed ID: 27266875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix metalloproteinases and their tissue inhibitors in cuprizone-induced demyelination and remyelination of brain white and gray matter.
    Skuljec J; Gudi V; Ulrich R; Frichert K; Yildiz O; Pul R; Voss EV; Wissel K; Baumgärtner W; Stangel M
    J Neuropathol Exp Neurol; 2011 Sep; 70(9):758-69. PubMed ID: 21865884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metalloproteinases control brain inflammation induced by pertussis toxin in mice overexpressing the chemokine CCL2 in the central nervous system.
    Toft-Hansen H; Buist R; Sun XJ; Schellenberg A; Peeling J; Owens T
    J Immunol; 2006 Nov; 177(10):7242-9. PubMed ID: 17082642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tenascin-R and C in multiple sclerosis lesions: relevance to extracellular matrix remodelling.
    Gutowski NJ; Newcombe J; Cuzner ML
    Neuropathol Appl Neurobiol; 1999 Jun; 25(3):207-14. PubMed ID: 10417662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased expression of distinct galectins in multiple sclerosis lesions.
    Stancic M; van Horssen J; Thijssen VL; Gabius HJ; van der Valk P; Hoekstra D; Baron W
    Neuropathol Appl Neurobiol; 2011 Oct; 37(6):654-71. PubMed ID: 21501208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
    Lopes Pinheiro MA; Kooij G; Mizee MR; Kamermans A; Enzmann G; Lyck R; Schwaninger M; Engelhardt B; de Vries HE
    Biochim Biophys Acta; 2016 Mar; 1862(3):461-71. PubMed ID: 26527183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenic implications of distinct patterns of iron and zinc in chronic MS lesions.
    Popescu BF; Frischer JM; Webb SM; Tham M; Adiele RC; Robinson CA; Fitz-Gibbon PD; Weigand SD; Metz I; Nehzati S; George GN; Pickering IJ; Brück W; Hametner S; Lassmann H; Parisi JE; Yong G; Lucchinetti CF
    Acta Neuropathol; 2017 Jul; 134(1):45-64. PubMed ID: 28332093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.